Paux, G. Regulatory considerations for Subgroup Analysis in Clinical Trials. Annual day of the French Society of Statistics’s (SFdS) Group Biopharmacy. Nov 27, 2014.
Dmitrienko, A. and Paux, G.From Sample Size Calculations to Clinical Trial Optimization. American Statistical Association Biopharmaceutical section webinar. Dec 4, 2014.
Paux, G. and Dmitrienko, A. Mediana: R package for power evaluation in clinical trials with multiplicity adjustment methods. 7th International Conference of the ERCIM WG on Computational and Methodological Statistics (ERCIM 2014). Dec 8, 2014.
Paux, G. and Dubois, F. Transitioning from algorithmic to adaptive model-based designs for Phase I dose-escalation trials in oncology at Servier. Symposium on Early Phase Dose Finding Methodology. Apr 16, 2015.
Paux, G. and Dmitrienko, A. Key Principles of Clinical Trial Simulations to Improve the Probability of Success in Late-Stage Trials. PSI Annual Conference. May 12, 2015.
Paux, G. and Dmitrienko, A. Clinical trial optimization approaches to Phase III trials with multiple objectives. Trends and Innovations in Clinical Trial Statistics. May 3, 2016.
Paux, G. and Dmitrienko, A. Clinical trial optimization approaches to Phase III trials with multiple objectives. CEN ISBS - Joint Conference on Biometrics & Biopharmaceutical Statistic. Aug 29, 2017.